title: Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer).
authors.affiliation: GEICO and MD Anderson Cancer Center Spain, Madrid, Spain. Electronic address: agonzalezm@seom.org.
authors.forename: Antonio
authors.initials: A
authors.lastname: Gonzalez-Martin
authors.affiliation: GINECO and Institut Claudius Regaud, Toulouse, France.
authors.forename: Laurence
authors.initials: L
authors.lastname: Gladieff
authors.affiliation: NSGO and Uppsala University Hospital, Uppsala, Sweden.
authors.forename: Bengt
authors.initials: B
authors.lastname: Tholander
authors.affiliation: Moscow Oncology Hospital No. 62, Moscow, Russian Federation.
authors.forename: Daniel
authors.initials: D
authors.lastname: Stroyakovsky
authors.affiliation: The Royal Marsden Hospital, London, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Gore
authors.affiliation: Università Cattolica Roma, Rome, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Scambia
authors.affiliation: Vall d'Hebron University Hospital, Barcelona, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Oaknin
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Vesna
authors.initials: V
authors.lastname: Sneller
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Freudensprung
authors.affiliation: MITO and Department of Urology and Gynecology, Istituto Nazionale Tumori Fondazione G. Pascale, IRCCS, Naples, Italy.
authors.forename: Sandro
authors.initials: S
authors.lastname: Pignata
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*